Clinical Trial: A 21 Day Pharmacokinetics Study in Papulopustular Rosacea

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Phase 1, Open Label, Multiple Center Study to Evaluate the Pharmacokinetics of Once-Daily CLS001 Topical Gel Under Maximal Use Conditions Administered for 21 Days in Subjects With Papulopustular

Brief Summary: The purpose of this study is to characterize the pharmacokinetics of once daily topical gel and confirm that steady state conditions are reached under maximal use conditions following 3 weeks of daily applications.